<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04510000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P01024</UniProt_ID>
  <Seq_Length>1663</Seq_Length>
  <Molecule_Weight>187148</Molecule_Weight>
  <KEGG_ID>hsa:718</KEGG_ID>
  <Orthology_ID>K03990</Orthology_ID>
  <EBI_ID>EBI-905851</EBI_ID>
  <Function_Summary>C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes.</Function_Summary>
  <Pfam_ID>PF00207:A2M@@PF07678:A2M_comp@@PF01835:A2M_N@@PF07703:A2M_N_2@@PF07677:A2M_recep@@PF01821:ANATO@@PF01759:NTR@@PF10569:Thiol-ester_cl</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Complement C3b alpha' chain</Alias>
      <Alias>Complement C3 beta chain</Alias>
      <Alias>Complement C3dg fragment</Alias>
      <Alias>Complement C3g fragment</Alias>
      <Alias>Complement C3 alpha chain</Alias>
      <Alias>Complement C3c alpha' chain fragment 1</Alias>
      <Alias>Complement C3c alpha' chain fragment 2</Alias>
      <Alias>Complement C3d fragment</Alias>
      <Alias>Complement C3f fragment</Alias>
      <Alias>C3a anaphylatoxin</Alias>
      <Alias>C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.</Detail>
      <Keyword>Receptor binding</Keyword>
      <Ontology_ID>GO:0005102</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Stops, prevents or reduces the activity of an endopeptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.</Detail>
      <Keyword>Endopeptidase inhibitor activity</Keyword>
      <Ontology_ID>GO:0004866</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>1216</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>549</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>1367</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>1161</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>1320</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>1042</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>1158</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>1521</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>1464</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>863</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>735</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>1094</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>1224</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>1115</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>1601</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>1619</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>592</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>314</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>603</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>592</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>469</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.</Detail>
      <Keyword>Positive regulation vascular endothelial growth factor production</Keyword>
      <Ontology_ID>GO:0010575</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the activation of any of the steps of the alternative pathway of the complement cascade which allows for the direct killing of microbes and the regulation of other immune processes.</Detail>
      <Keyword>Complement activation, alternative pathway</Keyword>
      <Ontology_ID>GO:0006957</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.</Detail>
      <Keyword>Complement activation, classical pathway</Keyword>
      <Ontology_ID>GO:0006958</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>1573</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>297</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>1571</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>489</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGPTSGPSLLLLLLTHLPLALGSPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPATNHMGNVTFTIPANREFKSEKGRNKFVTVQATFGTQVVEKVVLVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVNHKLLPVGRTVMVNIENPEGIPVKQDSLSSQNQLGVLPLSWDIPELVNMGQWKIRAYYENSPQQVFSTEFEVKEYVLPSFEVIVEPTEKFYYIYNEKGLEVTITARFLYGKKVEGTAFVIFGIQDGEQRISLPESLKRIPIEDGSGEVVLSRKVLLDGVQNPRAEDLVGKSLYVSATVILHSGSDMVQAERSGIPIVTSPYQIHFTKTPKYFKPGMPFDLMVFVTNPDGSPAYRVPVAVQGEDTVQSLTQGDGVAKLSINTHPSQKPLSITVRTKKQELSEAEQATRTMQALPYSTVGNSNNYLHLSVLRTELRPGETLNVNFLLRMDRAHEAKIRYYTYLIMNKGRLLKAGRQVREPGQDLVVLPLSITTDFIPSFRLVAYYTLIGASGQREVVADSVWVDVKDSCVGSLVVKSGQSEDRQPVPGQQMTLKIEGDHGARVVLVAVDKGVFVLNKKNKLTQSKIWDVVEKADIGCTPGSGKDYAGVFSDAGLTFTSSSGQQTAQRAELQCPQPAARRRRSVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLARSNLDEDIIAEENIVSRSEFPESWLWNVEDLKEPPKNGISTKLMNIFLKDSITTWEILAVSMSDKKGICVADPFEVTVMQDFFIDLRLPYSVVRNEQVEIRAVLYNYRQNQELKVRVELLHNPAFCSLATTKRRHQQTVTIPPKSSLSVPYVIVPLKTGLQEVEVKAAVYHHFISDGVRKSLKVVPEGIRMNKTVAVRTLDPERLGREGVQKEDIPPADLSDQVPDTESETRILLQGTPVAQMTEDAVDAERLKHLIVTPSGCGEQNMIGMTPTVIAVHYLDETEQWEKFGLEKRQGALELIKKGYTQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNLIAIDSQVLCGAVKWLILEKQKPDGVFQEDAPVIHQEMIGGLRNNNEKDMALTAFVLISLQEAKDICEEQVNSLPGSITKAGDFLEANYMNLQRSYTVAIAGYALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEATSYALLALLQLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPDHQELNLDVSLQLPSRSSKITHRIHWESASLLRSEETKENEGFTVTAEGKGQGTLSVVTMYHAKAKDQLTCNKFDLKVTIKPAPETEKRPQDAKNTMILEICTRYRGDQDATMSILDISMMTGFAPDTDDLKQLANGVDRYISKYELDKAFSDRNTLIIYLDKVSHSEDDCLAFKVHQYFNVELIQPGAVKVYAYYNLEESCTRFYHPEKEDGKLNKLCRDELCRCAEENCFIQKSDDKVTLEERLDKACEPGVDYVYKTRLVKVQLSNDFDEYIMAIEQTIKSGSDEVQVGQQRTFISPIKCREALKLEEKKHYLMWGLSSDFWGEKPNLSYIIGKDTWVEHWPEEDECQDEENQKQCQDLGAFTESMVVFGCPN</Protein_Seq>
    <DNA_Seq>CACTCCTCCCCATCCTCTCCCTCTGTCCCTCTGTCCCTCTGACCCTGCACTGTCCCAGCACCATGGGACCCACCTCAGGTCCCAGCCTGCTGCTCCTGCTACTAACCCACCTCCCCCTGGCTCTGGGGAGTCCCATGTACTCTATCATCACCCCCAACATCTTGCGGCTGGAGAGCGAGGAGACCATGGTGCTGGAGGCCCACGACGCGCAAGGGGATGTTCCAGTCACTGTTACTGTCCACGACTTCCCAGGCAAAAAACTAGTGCTGTCCAGTGAGAAGACTGTGCTGACCCCTGCCACCAACCACATGGGCAACGTCACCTTCACGATCCCAGCCAACAGGGAGTTCAAGTCAGAAAAGGGGCGCAACAAGTTCGTGACCGTGCAGGCCACCTTCGGGACCCAAGTGGTGGAGAAGGTGGTGCTGGTCAGCCTGCAGAGCGGGTACCTCTTCATCCAGACAGACAAGACCATCTACACCCCTGGCTCCACAGTTCTCTATCGGATCTTCACCGTCAACCACAAGCTGCTACCCGTGGGCCGGACGGTCATGGTCAACATTGAGAACCCGGAAGGCATCCCGGTCAAGCAGGACTCCTTGTCTTCTCAGAACCAGCTTGGCGTCTTGCCCTTGTCTTGGGACATTCCGGAACTCGTCAACATGGGCCAGTGGAAGATCCGAGCCTACTATGAAAACTCACCACAGCAGGTCTTCTCCACTGAGTTTGAGGTGAAGGAGTACGTGCTGCCCAGTTTCGAGGTCATAGTGGAGCCTACAGAGAAATTCTACTACATCTATAACGAGAAGGGCCTGGAGGTCACCATCACCGCCAGGTTCCTCTACGGGAAGAAAGTGGAGGGAACTGCCTTTGTCATCTTCGGGATCCAGGATGGCGAACAGAGGATTTCCCTGCCTGAATCCCTCAAGCGCATTCCGATTGAGGATGGCTCGGGGGAGGTTGTGCTGAGCCGGAAGGTACTGCTGGACGGGGTGCAGAACCCCCGAGCAGAAGACCTGGTGGGGAAGTCTTTGTACGTGTCTGCCACCGTCATCTTGCACTCAGGCAGTGACATGGTGCAGGCAGAGCGCAGCGGGATCCCCATCGTGACCTCTCCCTACCAGATCCACTTCACCAAGACACCCAAGTACTTCAAACCAGGAATGCCCTTTGACCTCATGGTGTTCGTGACGAACCCTGATGGCTCTCCAGCCTACCGAGTCCCCGTGGCAGTCCAGGGCGAGGACACTGTGCAGTCTCTAACCCAGGGAGATGGCGTGGCCAAACTCAGCATCAACACACACCCCAGCCAGAAGCCCTTGAGCATCACGGTGCGCACGAAGAAGCAGGAGCTCTCGGAGGCAGAGCAGGCTACCAGGACCATGCAGGCTCTGCCCTACAGCACCGTGGGCAACTCCAACAATTACCTGCATCTCTCAGTGCTACGTACAGAGCTCAGACCCGGGGAGACCCTCAACGTCAACTTCCTCCTGCGAATGGACCGCGCCCACGAGGCCAAGATCCGCTACTACACCTACCTGATCATGAACAAGGGCAGGCTGTTGAAGGCGGGACGCCAGGTGCGAGAGCCCGGCCAGGACCTGGTGGTGCTGCCCCTGTCCATCACCACCGACTTCATCCCTTCCTTCCGCCTGGTGGCGTACTACACGCTGATCGGTGCCAGCGGCCAGAGGGAGGTGGTGGCCGACTCCGTGTGGGTGGACGTCAAGGACTCCTGCGTGGGCTCGCTGGTGGTAAAAAGCGGCCAGTCAGAAGACCGGCAGCCTGTACCTGGGCAGCAGATGACCCTGAAGATAGAGGGTGACCACGGGGCCCGGGTGGTACTGGTGGCCGTGGACAAGGGCGTGTTCGTGCTGAATAAGAAGAACAAACTGACGCAGAGTAAGATCTGGGACGTGGTGGAGAAGGCAGACATCGGCTGCACCCCGGGCAGTGGGAAGGATTACGCCGGTGTCTTCTCCGACGCAGGGCTGACCTTCACGAGCAGCAGTGGCCAGCAGACCGCCCAGAGGGCAGAACTTCAGTGCCCGCAGCCAGCCGCCCGCCGACGCCGTTCCGTGCAGCTCACGGAGAAGCGAATGGACAAAGTCGGCAAGTACCCCAAGGAGCTGCGCAAGTGCTGCGAGGACGGCATGCGGGAGAACCCCATGAGGTTCTCGTGCCAGCGCCGGACCCGTTTCATCTCCCTGGGCGAGGCGTGCAAGAAGGTCTTCCTGGACTGCTGCAACTACATCACAGAGCTGCGGCGGCAGCACGCGCGGGCCAGCCACCTGGGCCTGGCCAGGAGTAACCTGGATGAGGACATCATTGCAGAAGAGAACATCGTTTCCCGAAGTGAGTTCCCAGAGAGCTGGCTGTGGAACGTTGAGGACTTGAAAGAGCCACCGAAAAATGGAATCTCTACGAAGCTCATGAATATATTTTTGAAAGACTCCATCACCACGTGGGAGATTCTGGCTGTGAGCATGTCGGACAAGAAAGGGATCTGTGTGGCAGACCCCTTCGAGGTCACAGTAATGCAGGACTTCTTCATCGACCTGCGGCTACCCTACTCTGTTGTTCGAAACGAGCAGGTGGAAATCCGAGCCGTTCTCTACAATTACCGGCAGAACCAAGAGCTCAAGGTGAGGGTGGAACTACTCCACAATCCAGCCTTCTGCAGCCTGGCCACCACCAAGAGGCGTCACCAGCAGACCGTAACCATCCCCCCCAAGTCCTCGTTGTCCGTTCCATATGTCATCGTGCCGCTAAAGACCGGCCTGCAGGAAGTGGAAGTCAAGGCTGCTGTCTACCATCATTTCATCAGTGACGGTGTCAGGAAGTCCCTGAAGGTCGTGCCGGAAGGAATCAGAATGAACAAAACTGTGGCTGTTCGCACCCTGGATCCAGAACGCCTGGGCCGTGAAGGAGTGCAGAAAGAGGACATCCCACCTGCAGACCTCAGTGACCAAGTCCCGGACACCGAGTCTGAGACCAGAATTCTCCTGCAAGGGACCCCAGTGGCCCAGATGACAGAGGATGCCGTCGACGCGGAACGGCTGAAGCACCTCATTGTGACCCCCTCGGGCTGCGGGGAACAGAACATGATCGGCATGACGCCCACGGTCATCGCTGTGCATTACCTGGATGAAACGGAGCAGTGGGAGAAGTTCGGCCTAGAGAAGCGGCAGGGGGCCTTGGAGCTCATCAAGAAGGGGTACACCCAGCAGCTGGCCTTCAGACAACCCAGCTCTGCCTTTGCGGCCTTCGTGAAACGGGCACCCAGCACCTGGCTGACCGCCTACGTGGTCAAGGTCTTCTCTCTGGCTGTCAACCTCATCGCCATCGACTCCCAAGTCCTCTGCGGGGCTGTTAAATGGCTGATCCTGGAGAAGCAGAAGCCCGACGGGGTCTTCCAGGAGGATGCGCCCGTGATACACCAAGAAATGATTGGTGGATTACGGAACAACAACGAGAAAGACATGGCCCTCACGGCCTTTGTTCTCATCTCGCTGCAGGAGGCTAAAGATATTTGCGAGGAGCAGGTCAACAGCCTGCCAGGCAGCATCACTAAAGCAGGAGACTTCCTTGAAGCCAACTACATGAACCTACAGAGATCCTACACTGTGGCCATTGCTGGCTATGCTCTGGCCCAGATGGGCAGGCTGAAGGGGCCTCTTCTTAACAAATTTCTGACCACAGCCAAAGATAAGAACCGCTGGGAGGACCCTGGTAAGCAGCTCTACAACGTGGAGGCCACATCCTATGCCCTCTTGGCCCTACTGCAGCTAAAAGACTTTGACTTTGTGCCTCCCGTCGTGCGTTGGCTCAATGAACAGAGATACTACGGTGGTGGCTATGGCTCTACCCAGGCCACCTTCATGGTGTTCCAAGCCTTGGCTCAATACCAAAAGGACGCCCCTGACCACCAGGAACTGAACCTTGATGTGTCCCTCCAACTGCCCAGCCGCAGCTCCAAGATCACCCACCGTATCCACTGGGAATCTGCCAGCCTCCTGCGATCAGAAGAGACCAAGGAAAATGAGGGTTTCACAGTCACAGCTGAAGGAAAAGGCCAAGGCACCTTGTCGGTGGTGACAATGTACCATGCTAAGGCCAAAGATCAACTCACCTGTAATAAATTCGACCTCAAGGTCACCATAAAACCAGCACCGGAAACAGAAAAGAGGCCTCAGGATGCCAAGAACACTATGATCCTTGAGATCTGTACCAGGTACCGGGGAGACCAGGATGCCACTATGTCTATATTGGACATATCCATGATGACTGGCTTTGCTCCAGACACAGATGACCTGAAGCAGCTGGCCAATGGTGTTGACAGATACATCTCCAAGTATGAGCTGGACAAAGCCTTCTCCGATAGGAACACCCTCATCATCTACCTGGACAAGGTCTCACACTCTGAGGATGACTGTCTAGCTTTCAAAGTTCACCAATACTTTAATGTAGAGCTTATCCAGCCTGGAGCAGTCAAGGTCTACGCCTATTACAACCTGGAGGAAAGCTGTACCCGGTTCTACCATCCGGAAAAGGAGGATGGAAAGCTGAACAAGCTCTGCCGTGATGAACTGTGCCGCTGTGCTGAGGAGAATTGCTTCATACAAAAGTCGGATGACAAGGTCACCCTGGAAGAACGGCTGGACAAGGCCTGTGAGCCAGGAGTGGACTATGTGTACAAGACCCGACTGGTCAAGGTTCAGCTGTCCAATGACTTTGACGAGTACATCATGGCCATTGAGCAGACCATCAAGTCAGGCTCGGATGAGGTGCAGGTTGGACAGCAGCGCACGTTCATCAGCCCCATCAAGTGCAGAGAAGCCCTGAAGCTGGAGGAGAAGAAACACTACCTCATGTGGGGTCTCTCCTCCGATTTCTGGGGAGAGAAGCCCAACCTCAGCTACATCATCGGGAAGGACACTTGGGTGGAGCACTGGCCCGAGGAGGACGAATGCCAAGACGAAGAGAACCAGAAACAATGCCAGGACCTCGGCGCCTTCACCGAGAGCATGGTTGTCTTTGGGTGCCCCAACTGACCACACCCCCATTCCCCCACTCCAGATAAAGCTTCAGTTATATCTCA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Plasma</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>C3</Gene_Name>
    <Gene_Alias>CPAMD1</Gene_Alias>
    <Gene_ID>718</Gene_ID>
    <Genbank_ACCN>NM_000064</Genbank_ACCN>
    <Protein_ACCN>NP_000055</Protein_ACCN>
    <HGNC_ID>1318</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/718</Gene_URL>
    <UCSC_ID>uc002mfm.3</UCSC_ID>
    <EMBL_ID>ENSG00000125730</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9Y279-1</Uniprot_ID>
      <Gene_Name>VSIG4</Gene_Name>
      <EBI_ID>EBI-903144</EBI_ID>
      <PPI_EBI_URL>EBI-905851,EBI-903144</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9Y279-2</Uniprot_ID>
      <Gene_Name>VSIG4</Gene_Name>
      <EBI_ID>EBI-903148</EBI_ID>
      <PPI_EBI_URL>EBI-905851,EBI-903148</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>C3 Deficiency</Disease_Name>
      <Disease_Detail>C3 Deficiency</Disease_Detail>
      <Disease_DB>C3D001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/c3_deficiency?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pediatric Systemic Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Pediatric Systemic Lupus Erythematosus</Disease_Detail>
      <Disease_DB>PDT035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pediatric_systemic_lupus_erythematosus?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Afibrinogenemia</Disease_Name>
      <Disease_Detail>Afibrinogenemia</Disease_Detail>
      <Disease_DB>AFB001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/afibrinogenemia?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>C3 Deficiency, Autosomal Recessive</Disease_Name>
      <Disease_Detail>C3 Deficiency</Disease_Detail>
      <Disease_DB>C3D002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/c3_deficiency_autosomal_recessive?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pneumococcal Meningitis</Disease_Name>
      <Disease_Detail>Pneumococcal Meningitis</Disease_Detail>
      <Disease_DB>PNM013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pneumococcal_meningitis?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Capillary Leak Syndrome</Disease_Name>
      <Disease_Detail>Capillary Leak Syndrome</Disease_Detail>
      <Disease_DB>CPL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/capillary_leak_syndrome?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glomerulonephritis</Disease_Name>
      <Disease_Detail>Glomerulonephritis</Disease_Detail>
      <Disease_DB>GLM007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glomerulonephritis?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Lupus Erythematosus</Disease_Detail>
      <Disease_DB>LPS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lupus_erythematosus?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculosis</Disease_Name>
      <Disease_Detail>Tuberculosis</Disease_Detail>
      <Disease_DB>TBR010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculosis?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atypical Hemolytic-Uremic Syndrome</Disease_Name>
      <Disease_Detail>Atypical Hemolytic-Uremic Syndrome</Disease_Detail>
      <Disease_DB>ATY010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atypical_hemolytic_uremic_syndrome?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multiple Sclerosis</Disease_Name>
      <Disease_Detail>Multiple Sclerosis</Disease_Detail>
      <Disease_DB>MLT020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_sclerosis?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arteriolosclerosis</Disease_Name>
      <Disease_Detail>Arteriolosclerosis</Disease_Detail>
      <Disease_DB>ART010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriolosclerosis?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dense Deposit Disease</Disease_Name>
      <Disease_Detail>Dense Deposit Disease</Disease_Detail>
      <Disease_DB>DNS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dense_deposit_disease?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Age Related Macular Degeneration</Disease_Name>
      <Disease_Detail>Age Related Macular Degeneration</Disease_Detail>
      <Disease_DB>AGR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/age_related_macular_degeneration?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Systemic Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Systemic Lupus Erythematosus</Disease_Detail>
      <Disease_DB>SYS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/systemic_lupus_erythematosus?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperapobetalipoproteinemia</Disease_Name>
      <Disease_Detail>Hyperapobetalipoproteinemia</Disease_Detail>
      <Disease_DB>HYP456</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperapobetalipoproteinemia?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>C3-Related Atypical Hemolytic-Uremic Syndrome</Disease_Name>
      <Disease_Detail>C3 Deficiency</Disease_Detail>
      <Disease_DB>C3R001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/c3_related_atypical_hemolytic_uremic_syndrome?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Drusen</Disease_Name>
      <Disease_Detail>Retinal Drusen</Disease_Detail>
      <Disease_DB>RTN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_drusen?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Age-Related Macular Degeneration 9</Disease_Name>
      <Disease_Detail>Age Related Macular Degeneration</Disease_Detail>
      <Disease_DB>AGR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/age_related_macular_degeneration_9?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Complement Deficiency</Disease_Name>
      <Disease_Detail>Complement Deficiency</Disease_Detail>
      <Disease_DB>CMP009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/complement_deficiency?search=C3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemolytic Uremic Syndrome, Atypical 5</Disease_Name>
      <Disease_Detail>Hemolytic-Uremic Syndrome</Disease_Detail>
      <Disease_DB>HML037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemolytic_uremic_syndrome_atypical_5?search=C3#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of Efb-C / C3d Complex</PDB_Title>
      <PDB_ID>2GOX</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GOX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A structural basis for complement inhibition by Staphylococcus aureus.</PubMed_Title>
      <Author>Hammel, M., et al.</Author>
      <Journal>Nat.Immunol.(2007)8:430-437</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17351618?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Complement Component C3b</PDB_Title>
      <PDB_ID>2I07</PDB_ID>
      <Resolution>4.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2I07</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of C3b reveals conformational changes that underlie complement activity.</PubMed_Title>
      <Author>Janssen, B.J., et al.</Author>
      <Journal>Nature(2006)444:213-216</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17051160?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The structure of the complex between complement receptor CR2 and its ligand complement fragment C3d</PDB_Title>
      <PDB_ID>3OED</PDB_ID>
      <Resolution>3.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OED</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A crystal structure of the complex between human complement receptor 2 and its ligand C3d.</PubMed_Title>
      <Author>van den Elsen, J.M., et al.</Author>
      <Journal>Science(2011)332:608-611</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21527715?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Complement Component C3c</PDB_Title>
      <PDB_ID>2A74</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A74</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of complement component C3 provide insights into the function and evolution of immunity.</PubMed_Title>
      <Author>Janssen, B.J., et al.</Author>
      <Journal>Nature(2005)437:505-511</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16177781?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Complement C3b in complex with Factors B and D</PDB_Title>
      <PDB_ID>2XWB</PDB_ID>
      <Resolution>3.49</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XWB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of C3B in Complex with Factors B and D Give Insight Into Complement Convertase Formation.</PubMed_Title>
      <Author>Forneris, F., et al.</Author>
      <Journal>Science(2010)330:1816</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21205667?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRIg bound to C3b</PDB_Title>
      <PDB_ID>2ICF</PDB_ID>
      <Resolution>4.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ICF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of C3b in complex with CRIg gives insights into regulation of complement activation.</PubMed_Title>
      <Author>Wiesmann, C., et al.</Author>
      <Journal>Nature(2006)444:217-220</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17051150?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Complement C3b: Insights into Complement Activation and Regulation</PDB_Title>
      <PDB_ID>2HR0</PDB_ID>
      <Resolution>2.26</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HR0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of complement C3b provides insights into complement activation and regulation.</PubMed_Title>
      <Author>Abdul Ajees, A., et al.</Author>
      <Journal>Nature(2006)444:221-225</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17051152?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRIg bound to C3c</PDB_Title>
      <PDB_ID>2ICE</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ICE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of C3b in complex with CRIg gives insights into regulation of complement activation.</PubMed_Title>
      <Author>Wiesmann, C., et al.</Author>
      <Journal>Nature(2006)444:217-220</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17051150?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CR2-C3D COMPLEX STRUCTURE</PDB_Title>
      <PDB_ID>1GHQ</PDB_ID>
      <Resolution>2.04</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GHQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of complement receptor 2 in complex with its C3d ligand.</PubMed_Title>
      <Author>Szakonyi, G., et al.</Author>
      <Journal>Science(2001)292:1725-1728</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11387479?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Staphylococcal Complement Inhibitor (SCIN) in complex with Human Complement C3c</PDB_Title>
      <PDB_ID>3NMS</PDB_ID>
      <Resolution>4.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NMS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b.</PubMed_Title>
      <Author>Garcia, B.L., et al.</Author>
      <Journal>J.Mol.Biol.(2010)402:17-29</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20654625?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>C3 CONVERTASE (C3BBB) STABILIZED BY SCIN</PDB_Title>
      <PDB_ID>2WIN</PDB_ID>
      <Resolution>3.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WIN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Functional Implications of the Alternative Complement Pathway C3 Convertase Stabilized by a Staphylococcal Inhibitor.</PubMed_Title>
      <Author>Rooijakkers, S.H., et al.</Author>
      <Journal>Nat.Immunol.(2009)10:721-727</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19503103?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complement components factor H CCP19-20 and C3d in complex</PDB_Title>
      <PDB_ID>3OXU</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OXU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>An experimentally derived model for the complex between factor H and C3b on a self surface</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY CRYSTAL STRUCTURE OF C3D: A C3 FRAGMENT AND LIGAND FOR COMPLEMENT RECEPTOR 2</PDB_Title>
      <PDB_ID>1C3D</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1C3D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2.</PubMed_Title>
      <Author>Nagar, B., et al.</Author>
      <Journal>Science(1998)280:1277-1281</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9596584?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF FACTOR H DOMAINS 19-20 IN COMPLEX WITH COMPLEMENT C3D</PDB_Title>
      <PDB_ID>2XQW</PDB_ID>
      <Resolution>2.31</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XQW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Dual Interaction of Factor H with C3D and Glycosaminoglycans in Host-Nonhost Discrimination by Complement.</PubMed_Title>
      <Author>Kajander, T., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2011)108:2897</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21285368?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Complement C3b in Complex with Factor B</PDB_Title>
      <PDB_ID>2XWJ</PDB_ID>
      <Resolution>4.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XWJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of C3B in Complex with Factors B and D Give Insight Into Complement Convertase Formation.</PubMed_Title>
      <Author>Forneris, F., et al.</Author>
      <Journal>Science(2010)330:1816</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21205667?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human C3c in complex with the inhibitor compstatin</PDB_Title>
      <PDB_ID>2QKI</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QKI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.</PubMed_Title>
      <Author>Janssen, B.J., et al.</Author>
      <Journal>J.Biol.Chem.(2007)282:29241-29247</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17684013?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV IN COMPLEX WITH COMPLEMENT FRAGMENT C3D</PDB_Title>
      <PDB_ID>2WY8</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WY8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Structural Basis for Staphylococcal Complement Subversion: X-Ray Structure of the Complement- Binding Domain of Staphylococcus Aureus Protein Sbi in Complex with Ligand C3D.</PubMed_Title>
      <Author>Clark, E.A., et al.</Author>
      <Journal>Mol.Immunol.(2011)48:452</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21055811?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4</PDB_Title>
      <PDB_ID>2WII</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WII</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Complement Fragment C3B-Factor H and Implications for Host Protection by Complement Regulators.</PubMed_Title>
      <Author>Wu, J., et al.</Author>
      <Journal>Nat.Immunol.(2009)10:728-733</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19503104?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV IN COMPLEX WITH COMPLEMENT FRAGMENT C3D REVEALING AN ALTERNATIVE BINDING MODE</PDB_Title>
      <PDB_ID>2WY7</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WY7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Structural Basis for Staphylococcal Complement Subversion: X-Ray Structure of the Complement- Binding Domain of Staphylococcus Aureus Protein Sbi in Complex with Ligand C3D.</PubMed_Title>
      <Author>Clark, E.A., et al.</Author>
      <Journal>Mol.Immunol.(2011)48:452</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21055811?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF CR2 SCR 1-2 IN ITS COMPLEX WITH C3D BY X-RAY SCATTERING</PDB_Title>
      <PDB_ID>1W2S</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1W2S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of the Complex between Cr2 Scr 1-2 and C3D of Human Complement: An X-Ray Scattering and Sedimentation Modelling Study.</PubMed_Title>
      <Author>Gilbert, H.E., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:859</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15713468?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Efb-C (N138A) / C3d Complex</PDB_Title>
      <PDB_ID>3D5R</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D5R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.</PubMed_Title>
      <Author>Haspel, N., et al.</Author>
      <Journal>Protein Sci.(2008)17:1894-1906</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18687868?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of a truncated form of Staphylococcal Complement Inhibitor B bound to human C3c at 3.4 Angstrom resolution</PDB_Title>
      <PDB_ID>3T4A</PDB_ID>
      <Resolution>3.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3T4A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Diversity in the C3b Convertase Contact Residues and Tertiary Structures of the Staphylococcal Complement Inhibitor (SCIN) Protein Family.</PubMed_Title>
      <Author>Garcia, B.L., et al.</Author>
      <Journal>J.Biol.Chem.(2012)287:628-640</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22086928?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complement components factor H CCP19-20 (S1191L mutant) and C3D in complex</PDB_Title>
      <PDB_ID>3RJ3</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RJ3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and functional characterization of the product of disease-related factor h gene conversion.</PubMed_Title>
      <Author>Herbert, A.P., et al.</Author>
      <Journal>Biochemistry(2012)51:1874-1884</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22320225?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>C3b in complex with a C3b specific Fab</PDB_Title>
      <PDB_ID>3G6J</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3G6J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement</PubMed_Title>
      <Author>Katschke, K.J., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:10473-10479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19196712?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Efb-C (R131A) / C3d Complex</PDB_Title>
      <PDB_ID>3D5S</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D5S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.</PubMed_Title>
      <Author>Haspel, N., et al.</Author>
      <Journal>Protein Sci.(2008)17:1894-1906</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18687868?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Complement Component C3</PDB_Title>
      <PDB_ID>2A73</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A73</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of complement component C3 provide insights into the function and evolution of immunity.</PubMed_Title>
      <Author>Janssen, B.J., et al.</Author>
      <Journal>Nature(2005)437:505-511</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16177781?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Staphylococcal Complement Inhibitor (SCIN) in complex with Human Complement Component C3b</PDB_Title>
      <PDB_ID>3L5N</PDB_ID>
      <Resolution>7.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L5N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b.</PubMed_Title>
      <Author>Garcia, B.L., et al.</Author>
      <Journal>J.Mol.Biol.(2010)402:17-29</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20654625?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Staphylococcal Complement Inhibitor (SCIN) in complex with Human Complement Component C3c</PDB_Title>
      <PDB_ID>3L3O</PDB_ID>
      <Resolution>3.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L3O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b.</PubMed_Title>
      <Author>Garcia, B.L., et al.</Author>
      <Journal>J.Mol.Biol.(2010)402:17-29</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20654625?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Ehp / C3d complex</PDB_Title>
      <PDB_ID>2NOJ</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2NOJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Characterization of Ehp, a Secreted Complement Inhibitory Protein from Staphylococcus aureus.</PubMed_Title>
      <Author>Hammel, M., et al.</Author>
      <Journal>J.Biol.Chem.(2007)282:30051-30061</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17699522?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b</PDB_Title>
      <PDB_ID>3OHX</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OHX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b.</PubMed_Title>
      <Author>Garcia, B.L., et al.</Author>
      <Journal>J.Mol.Biol.(2010)402:17-29</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20654625?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05134</Pathway_ID>
      <Pathway_Title>Legionellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05140</Pathway_ID>
      <Pathway_Title>Leishmaniasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05134</Pathway_ID>
      <Pathway_Title>Legionellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05140</Pathway_ID>
      <Pathway_Title>Leishmaniasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05150</Pathway_ID>
      <Pathway_Title>Staphylococcus aureus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.cac.f.e.b.html</SCOP_URL>
    <CATH_Class>Class 1: Mainly Alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1c3d</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Protein-induced</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00170297</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>